- Price
- $72.32
- Day
- +0.79%
- Mkt Cap
- $3.31B
- 52W Range
- $46.30 – $74.99
- Volume
- 361.5K
- Beta
- 0.39
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Glenmede Trust Co. NA lowered its stake in Ashland Inc. (NYSE: ASH) by 8.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 191,305 shares of the basic materials company's stock after selling 17,450 shares during the quarter. Glenmede Trust Co.
Read full article
Ashland Inc. (ASH) Q3 2026 Earnings Call Transcript
Read full article
Ashland Inc (NYSE:ASH) on Tuesday posted better-than-expected earnings for the second quarter.
Read full article
Ashland NYSE: ASH reported higher sales across all four business units in its fiscal third quarter of 2026, supported by volume growth, pricing actions and demand in its Life Sciences and Personal Care operations. The company reaffirmed its full-year sales and adjusted EBITDA outlook, while lowering its adjusted earnings-per-share growth forecast because of a higher tax rate tied to unfavorable discrete items.
Read full article
ASH's Q3 sales beat estimates as volume growth lifted all segments, but adjusted earnings missed and the company lowered its fiscal 2026 EPS growth outlook.
Read full article
WILMINGTON, Del., July 28, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), a global leader in additives and specialty ingredients, today announced the appointments of two new independent members of the Company Board of Directors and the formation of a Capital Allocation Advisory Committee as part of entry into a cooperation agreement with Ancora Holdings Group, LLC, a meaningful stockholder.
Read full article
Sales of $497 million, up seven percent from the prior-year quarter Income from continuing operations of $41 million, or $0.89 per diluted share Adjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $47 million, or $1.02 per diluted share Net income of $16 million, or $0.35 per diluted share Sales volumes rose six percent from the prior-year quarter, with gains achieved across all business units Adjusted EBITDA of $109 million, down four percent from the prior-year quarter, primarily reflecting growth in Life Sciences and Personal Care, more than offset by lower Specialty Additives and Intermediates earnings Cash flows provided by operating activities of $121 million; Ongoing Free Cash Flow2 of $103 million Reaffirming full‑year fiscal 2026 sales guidance of $1,835-$1,870 million and Adjusted EBITDA guidance of $385-$400 million WILMINGTON, Del., July 28, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the third quarter of fiscal year 2026, which ended June 30, 2026, and reaffirmed its full-year fiscal 2026 sales and Adjusted EBITDA outlook.
Read full article
Although the revenue and EPS for Ashland (ASH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read full article
Ashland (ASH) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.04 per share a year ago.
Read full article
Ashland (ASH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article